Stay updated on CTL019 in Adult ALL: Efficacy & Safety Clinical Trial
Sign up to get notified when there's something new on the CTL019 in Adult ALL: Efficacy & Safety Clinical Trial page.

Latest updates to the CTL019 in Adult ALL: Efficacy & Safety Clinical Trial page
- Check3 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedDifference0.7%
- Check32 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check39 days agoChange DetectedDifference0.7%
- Check46 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study information regarding the efficacy and safety of CTL019 for adult patients with relapsed and refractory B-cell Acute Lymphoblastic Leukemia, while adding a new version number and a reference to B-cell Acute Lymphoblastic Leukemia.SummaryDifference54%
- Check53 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to CTL019 in Adult ALL: Efficacy & Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTL019 in Adult ALL: Efficacy & Safety Clinical Trial page.